Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Price to Earnings (2017 - 2023)

Updated

Aptevo Therapeutics' (APVO) Price to Earnings came in at 0.77 for Q1 2023, down 49.2% from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Price to Earnings (2017 - 2023) Analysis & Trends

For FY2022, Aptevo Therapeutics' Price to Earnings stood at 1.52.

  • The Q1 2023 figure stands as the lowest quarterly Price to Earnings in data going back to Q3 2017.
  • According to Business Quant data, Price to Earnings for the three prior quarters was 1.52 (Q4 2022), 2.51 (Q3 2022) and 2.68 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.77
Dec 31, 2022 1.52
Sep 30, 2022 2.51
Jun 30, 2022 2.68
Jun 30, 2018 110.76
Mar 31, 2018 26.27
Dec 31, 2017 14.97
Sep 30, 2017 31.54
API Access

Aptevo Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=APVO&period=max&api_key=YOUR_API_KEY